Literature DB >> 23804912

The role of tricuspid valve surgery in the late management of tetralogy of fallot: collective review.

Julie W Cheng1, Hyde Russell, Robert D Stewart, Jamie Thomas, Carl L Backer, Constantine Mavroudis.   

Abstract

While surgical repair of tetralogy of Fallot (TOF) is generally associated with good early outcomes, late complications affect long-term survival and may require reoperation. Pulmonary regurgitation (PR) and tricuspid regurgitation (TR) may increase the risk of arrhythmias, reduced cardiac function, and sudden death. Tricuspid valve function can be compromised secondarily in the setting of PR or directly as a result of injury or alteration of the valve related to the original TOF repair. This article reviews the etiologic mechanisms, pathophysiological implications, and surgical interventions for TR. Effective management following TOF repair requires consideration of TR to optimize late outcomes.

Entities:  

Keywords:  pulmonary regurgitation; reoperation for tetralogy of Fallot; tetralogy of Fallot; tricuspid annuloplasty; tricuspid regurgitation

Year:  2012        PMID: 23804912     DOI: 10.1177/2150135112450037

Source DB:  PubMed          Journal:  World J Pediatr Congenit Heart Surg        ISSN: 2150-1351


  3 in total

Review 1.  Pulmonary valve replacement after repaired Tetralogy of Fallot.

Authors:  Hideki Tatewaki; Akira Shiose
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-19

2.  Thoracoscopic assistance in tricuspid valvuloplasty in an unarrested state: a case report and literature review.

Authors:  Feng Zhao; Qingliang Chen; Zhigang Guo; Nan Jiang
Journal:  Ann Transl Med       Date:  2020-12

3.  Tricuspid Valve Intervention at the Time of Pulmonary Valve Replacement in Adults With Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Jef Van den Eynde; Connor P Callahan; Mauro Lo Rito; Nabil Hussein; Horacio Carvajal; Alvise Guariento; Arjang Ruhparwar; Alexander Weymann; Werner Budts; Marc Gewillig; Michel Pompeu Sá; Shelby Kutty
Journal:  J Am Heart Assoc       Date:  2021-12-07       Impact factor: 6.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.